Monopar Therapeutics
MNPR
#7829
Rank
HK$1.91 B
Marketcap
HK$313.80
Share price
-0.88%
Change (1 day)
1,133.30%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2023 (TTM): -HK$6.03

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$5.97. In 2022 the company made an earnings per share (EPS) of -HK$6.44 a decrease over its 2021 EPS that were of -HK$5.74.

EPS history for Monopar Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$6.03-6.29%
2022-HK$6.4412.16%
2021-HK$5.7427.59%
2020-HK$4.5043.71%
2019-HK$3.1333.52%
2018-HK$2.34-80.97%
2017-HK$12.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.91 183.12%๐Ÿ‡บ๐Ÿ‡ธ USA